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ATM Mediates pRB Function To Control DNMT1 Protein Stability
and DNA Methylation
Awad Shamma,a Misa Suzuki,a Naoyuki Hayashi,a,b Masahiko Kobayashi,b Nobunari Sasaki,a Takumi Nishiuchi,c Yuichiro Doki,d
Takahiro Okamoto,e Susumu Kohno,a Hayato Muranaka,a Shunsuke Kitajima,a Ken-ichi Yamamoto,b Chiaki Takahashia
Division of Oncology and Molecular Biologya and Division of Molecular Pathology,b Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan; Advanced
Science Research Center, Kanazawa University, Kanazawa, Ishikawa, Japanc; Department of Gastroenterological Surgery, Osaka University, Graduate School of Medicine,
Suita, Osaka, Japand; Department of Endocrine Surgery, Tokyo Women’s Medical University, Tokyo, Japane
The retinoblastoma tumor suppressor gene (RB) product has been implicated in epigenetic control of gene expression owing to
its ability to physically bind to many chromatin modifiers. However, the biological and clinical significance of this activity was
not well elucidated. To address this, we performed genetic and epigenetic analyses in an Rb-deficient mouse thyroid C cell tumor
model. Here we report that the genetic interaction of Rb and ATM regulates DNMT1 protein stability and hence controls the
DNAmethylation status in the promoters of at least the Ink4a, Shc2, FoxO6, andNoggin genes. Furthermore, we demonstrate
that inactivation of pRB promotes Tip60 (acetyltransferase)-dependent ATM activation; allows activated ATM to physically bind
to DNMT1, forming a complex with Tip60 and UHRF1 (E3 ligase); and consequently accelerates DNMT1 ubiquitination driven
by Tip60-dependent acetylation. Our results indicate that inactivation of the pRB pathway in coordination with aberration in
the DNA damage response deregulates DNMT1 stability, leading to an abnormal DNAmethylation pattern andmalignant
progression.
The retinoblastoma tumor suppressor gene (RB) is prevalentlymutated at the initiation of retinoblastoma, osteosarcoma,
and small-cell lung cancer. However, in the majority of human
cancers, retinoblastoma protein (pRB) inactivation is frequently
detected during tumor progression and is implicated in various
facets of malignant behaviors (1). This suggests that pRB may
possessmore functions beyond its well-known roles in the control
of the cell cycle and differentiation (2, 3). Previous studies dem-
onstrated the direct interaction of pRB with a number of epige-
netic modifiers carrying the LXCXEmotif, including DNAmeth-
yltransferase 1 (DNMT1) (4, 5). pRB has been suggested to play a
certain role in nuclear reprogramming in embryonic stem (ES)
cells, induced pluripotent stem (iPS) cells, mouse embryonic fi-
broblasts (MEFs), as well as tumor cells (6–10). Furthermore, RB
loss was recently shown to contribute to the progression of human
retinoblastoma via epigenetic modifications (11). However, the
precise mechanism and target genes of the pRB epigenetic func-
tion are still largely unknown.
pRB inactivation induces DNA double-strand breaks (DSBs)
via multiple pathways (12–17). The MRN (Mre11, Rad50, and
NBS1) sensor complex detects DSBs, rapidly activates ataxia tel-
angiectasiamutated (ATM), and recruits ATM to the site of DSBs.
ATM then activates a number of transducers, such as MDC1,
53BP1, and BRCA1, and effector kinases, such as Chk2. These
proteins subsequently activate molecules required for DSB repair,
including the histone variant H2AX (18–20). Our previous study
demonstrated that some components of the DNA damage re-
sponse (DDR) are activated upon Rb loss in vivo and in vitro (15).
We therefore speculated that ATMmight mediate pRB functions
to regulate the DDR pathway.
C cell (calcitonin-producing cell) tumors developed in Rb/
mice are precancerous and display many features of the DDR and
cellular senescence. Early-stage Rb-deficient C cell tumors exhib-
ited many features of the DDR, including activated ATM, but few
features of cellular senescence (15). In contrast, cellular senes-
cence markers were predominant in late-stage Rb-deficient C cell
tumors, and simultaneous deletion of senescence-inducing genes,
such as Ink4a, Arf, or Suv39h1, allowed Rb-deficient C cells to
directly develop into highlymalignant tumors (15). Therefore, we
thought further genetic analysis of Rb/-based composite
knockoutmice (15, 21–23)might enable us to elucidate themech-
anism that links DDR signals to cellular senescence in vivo. To
address this, we initiated the current study by analyzingmice lack-
ing both Rb and ATM. We then discovered that pRB and ATM
coordinately regulateDNAmethylation by affectingDNMT1pro-
tein stability.
MATERIALS AND METHODS
Mouse strains and genotyping. Rb/ mice (a gift from T. Jacks) (21)
that had been backcrossed to the C57BL/6J strain for 5 to 7 generations
and inbred were crossed with Ink4a/ (a gift from N. Sharpless) (24) or
ATM/ (a gift from J.McKinnon) (25)mice similarly backcrossed to the
C57BL/6J strain for at least 5 generations. The resultant F1 progenies were
intercrossed to generate F2 mice. Progenies obtained by intercrossing F2
mice were inbred and used in this study. Mouse genotyping was per-
formed as described previously (21, 24, 25). Animals were handled in
accordance with the guidelines of Kanazawa University.
Retroviruses and plasmids. pCDNA3-YFP-Flag-ATM and -YFP-
Flag-ATMS1981A were gifts from David Chen (26). MaRXIVfhygro-
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hDNMT1 was a gift from E. Hara. pEGFPcl-Tip60 and pOZN-Tip60-
Flag-HA (27) were gifts from T. Ikura. pLXSB-RB was described
previously (15). pRK5-HA-Ubiquitin-WT (28) was purchased from Ad-
dgene (Boston,MA). For retrovirus production, EcoPak2 (Clontech) cells
were used. Transfection of MEFs or the C cell tumor cell line was per-
formed by using FuGene6 (Roche). MEFs or AC232 cells infected with
pBabe-puro or pLXSB vectors were selected with 4g/ml puromycin or 8
g/ml blasticidin S, respectively, for approximately 36 to 48 h.
Cell culture. Primary C cell adenocarcinoma cell lines were derived as
described previously (15). MEFs were prepared from embryonic day 10.0
(E10.0) or E12.5 embryos derived by intercrossing Rb/; ATM/ or
Rb/; Ink4a/ mice. The 3T3 protocol (3-day transfer, inoculum of
3 105 cells) assay was performed as described previously (15).
Antibodies. For immunohistochemistry, immunofluorescence (IF),
immunoblotting, or chromatin immunoprecipitation (ChIP) assays,
mouse or rabbit antibodies specific to the following proteins were used:
proliferating cell nuclear antigen (PCNA) (catalog no. SC-7907; Santa
Cruz), Ki67 (catalog no. AB15580; Abcam), H2AX (catalog no. 05-636;
Upstate), ATM phosphorylated at serine 1981 (ATMpS1981) (catalog no.
200-301-500; Rockland) (for immunohistochemistry), p53pS15 (catalog
no. PC386; Calbiochem), histone H3 trimethylated at lysine 9
(H3K9me3) (catalog no. 07-442; Upstate), heterochromatin protein 1
(HP1) (catalog no. MAB3450; Chemicon), p16INK4a (catalog no. SC-
1661), calcitonin (catalog no. SC-20725), carcinoembryonic antigen
(CEA) (catalog no. AB33562), ATMpS1981 (catalog no. 200-301-400;
Rockland), Suv39H1 (catalog no. AB12405; Abcam), ARF (catalog no.
AB80), pRBL2 (catalog no. SC-56178), Chk2pT68 (catalog no. AB38461),
p21 (catalog no. 556430; BD),-tubulin (catalog no. CP06; Calbiochem),
pRB (catalog no. 554136 [BD], MK-15-3 [MBL], and SC-50), DNMT1
(catalog no. 70-203 [Bioacademia Inc.] and AB13537), ubiquitin (catalog
no. 3933, Cell Signaling), acetylated lysine (catalog no. 9441; Cell Signal-
ing), HDAC1 (catalog no. SC-7872), UHRF1 (catalog no. AB57083),
Tip60 (catalog no. AB79373), DNMT3b (catalog no. SC-81252), ataxia
telangiectasia Rad-3-related protein kinase (ATR) (catalog no. SC-
1666328), ATM (catalog no. AB78), hemagglutinin (HA) (catalog no.
3F10; Roche), anti-FLAG (catalog no. F4042; Sigma), histone H3K4me2
(catalog no. AB32356), and histone H3K9me3 (catalog no. AB8898).
Staining of genetically unmodified (wild-type) thyroid tissues was per-
formed in our previouswork (15) formost of the proteins examined in the
current study.
Tagged proteins.HA-tagged DNMT1 was constructed by inserting
a PCR-amplified fragment of MaRXIVfhygro-hDNMT1 into pBabe-
puro. pEF-BOS-3HA-ATM, -3HA-ATM-CD (D2870A, kinase dead),
-3HA-ATM-BD, -3HA-ATM-ES, -3HA-ATM-KS, -3HA-ATM-PM,
and -3HA-ATM-KD were constructed by inserting PCR-amplified or
restriction-digested fragments of human ATM (hATM) into pEF-BOS
(29). pEF-BOS-FLAG-DNMT1-MS, -FLAG-DNMT1-KS, -3HA-
DNMT1-D2, -3HA-DNMT1-D3, -3HA-DNMT1-D4, and -3HA-
DNMT1-D5 were constructed by inserting a PCR-amplified fragment of
hDNMT1 cDNA into pEF-BOS. Structures of these tagged ATM and
DNMT1 fragments are shown in Fig. S8 in the supplemental material.
Immunohistochemistry. Paraffin-embedded mouse C cell tumors,
human medullary thyroid carcinomas (MTCs), and human esophageal
cancers were immunostained as described previously (15).
Immunofluorescence. Texas Red-conjugated goat anti-mouse or
Alexa Fluor 488-conjugated goat anti-rabbit antibody (catalog no. T862
and A11034, respectively; Molecular Probes) was used as the secondary
antibody. DNAwas visualized by staining with 4=,6-diamino-2-phenylin-
dole (DAPI).
Immunoblotting.Whole-cell lysates were prepared in MLB buffer or
in acid extraction buffer as described previously (15).
Cell fractionation. Collected cells were lysed in solution A (10 mM
HEPES [pH 7.9], 10 mMKCl, 1.5 mMMgCl2, 0.34 M sucrose, 10% glyc-
erol, 1 mM dithiothreitol, protease and phosphatase inhibitors, and 0.1%
Triton X-100). The cytoplasmic fraction (C) was harvested from super-
natants after centrifugation at 1,300 rpm for 5min. The nuclear pellet was
washed once with solution A and relysed in solution B (3 mM EDTA, 0.2
mM EGTA, 1 mM dithiothreitol, and protease and phosphatase inhibi-
tors). The soluble nuclear fraction (N) was obtained from supernatants
after centrifugation at 1,700 rpm for 5min. The chromatin pellet (Ch)was
washed twice in solution B, collected by centrifugation at 10,000 rpm for
3 min, and resolved in a loading buffer for SDS-PAGE.
Immunoprecipitation.Cell lysates were immunoreactedwith specific
antibodies and analyzed as described previously (15).
Colony formation assays.A colony formation assaywas performed as
described previously (15).
RNA interference. Mission TRC short hairpin RNA (shRNA) target
sets for ATM (TRCN0000012643 and TRCN0000012647), CDKN2A
(TRCN0000077815 and TRCN0000077816), DNMT1 (TRCN0000225698
and TRCN0000225700), and Tip60 (TRCN0000039302 and
TRCN0000039303) and the TurboGFP shRNA control vector (SHC004)
were purchased from Sigma-Aldrich.
DNAmethylation analysis.Genomic DNA sequences retrieved from
the Mouse Genome Informatics (MGI) database were searched for CpG
islands and specific primers by using the Methyl sequence software pro-
vided by Applied Bioscience. Bisulfite modification of DNA was per-
formed by using a Methyl Easy Xceed Rapid DNA bisulfite modification
kit (catalog no.ME002; HumanGenetic Signature) and amplified by PCR
using the bisulfite sequencing-specific primers listed in Table S4 in the
supplemental material. The amplified DNA fragment was subcloned into
T-Vector pMD20 (catalog no. 3270; TaKaRa Bio). Clones were screened
by colony PCR, and plasmid DNA was sequenced by using the KB-3130
sequencer (Applied Biosystems). Bisulfite sequencing data were analyzed
by using the Quantification Tool for Methylation Analysis (QUMA) pro-
vided by RIKEN (http://quma.cdb.riken.jp/). Statistical analysis was per-
formed by using the same program.
ChIP assay.AChIP assay was performed as described previously (15).
Briefly, cells were cross-linked with 1% formaldehyde for 10 min at room
temperature, and the reaction was terminated with 0.125 M glycine. The
cells were then lysed in lysis buffer (catalog no. SC-45000), resuspended in
high-salt lysis buffer (catalog no. SC-45001), and sonicated for 5 cycles of
30 s. Five hundred micrograms of protein was then immunoprecipitated
with anti-H3K4me2 (catalog no. AB32356), anti-H3K9me3 (catalog no.
AB8898), or anti-DNMT1 (catalog no. AB13537) antibodies. The DNA
was phenol extracted, and the promoters of genes were amplified by PCR
(ChIP). Quantitative PCR (quantitative ChIP) was performed by using
Fast SYBR greenmastermix (Applied Biosystems) with a Light Cycler 480
II instrument (Roche), according to the protocols provided by the man-
ufacturers. The sequences of primers used for these amplifications are
indicated in Table S5 in the supplemental material, and their locations on
the Ink4a promoter region are shown in Fig. S6B in the supplemental
material.
DNMT1 activity assay. DNMT1 activity was measured by using the
DNMT1 direct activity assay kit (catalog no. 52050L; BPS Bioscience),
according to the manufacturer’s protocol. Briefly, protein lysates were
incubated with the reaction mixture for 1 h with rocking at 4°C. The
reactionmixture was placed onto a substrate-coated plate, incubated with
anti-5-methylcytosine antibody, and then incubated with horseradish
peroxidase (HRP)-labeled secondary antibody and HRP chemilumines-
cent substrate. Chemiluminescence of the samples was immediately mea-
sured by using a Fluoroscan Ascent FL instrument (Thermo Electric Cor-
poration).
Microarray.Rb/;ATM/MEFswere transfected using nucleofec-
tion (nucleofected) with 0.5 g pBabe-puro plus 5.0 g pCDNA3-YFP-
Flag-ATM or an empty vector or infected with lentiviruses expressing
shRNAs that target DNMT1 and selected with 4 g/ml puromycin or 8
g/ml blasticidin S for 36 to 48 h. Selected cells were grown for a further 48
h in normal culture medium supplemented with 10% fetal bovine serum
(FBS) and harvested on ice, and RNA was extracted by using the RNeasy
kit (Qiagen Inc.). The quality of the RNA samples was assessed by using
Shamma et al.
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the RNA 6000 Nano LabChip kit (Bioanalyzer 2100; Agilent Technolo-
gies). One-color microarray analysis was performed by using an Agilent
mouse whole-genome 4X44k Oligo Microarray (Agilent Technologies),
as previously described (30).
Human tumors. Tumors from patients with MTCs were surgically
removed at the Department of Endocrine Surgery; were diagnosed at the
Department of Pathology, TokyoWomen’s Medical University; and were
analyzed according to the guidelines of TokyoWomen’s Medical Univer-
sity. Esophageal squamous cell carcinoma (SCC) tumors were surgically
removed at the Department of Gastroenterological Surgery; were diag-
nosed at the Department of Pathology, Graduate school of Medicine,
Osaka University; and were analyzed according to the guidelines of Osaka
University. Patients did not receive chemotherapy or radiation preopera-
tively.
Comet assay.AComet assay reagent kit was purchased fromTrevigen
(catalog no. 4250-050K), and assays were performed as previously de-
scribed (15).
BrdU incorporation. Bromodeoxyuridine (BrdU) incorporation was
measured as described previously (15).
Bisulfite PCR. Methylation of the Ink4a promoter was evaluated by
nested PCR with unmethylation- and methylation-specific primers by
using the 5= untranslated region of Ink4a (Gene bank accession no.
U47018), as previously described (24, 31). Bisulfite modification of DNA
was performed by using a MethylEasy DNA bisulfite modification kit
(catalog no. ME001; Human Genetic Signature). The sequences of the
unmethylation- or methylation-specific PCR primers are listed in Table
S2 in the supplemental material.
RT-PCR. Total RNA was extracted by using the RNeasy minikit from
Qiagen (catalog no. 74104), and reverse transcription-PCR (RT-PCR)
was performed by using the TaKaRa RNA PCR kit (catalog no. RR019A).
The sequences of specific primers are shown in Table S3 in the supple-
mental material.
Microarray data accessionnumber.Themicroarray data described in
this study have been deposited in the NCBI Gene Expression Omnibus
database under accession number GSE47501 (http://www.ncbi.nlm.nih
.gov/geo/query/acc.cgi?accGSE47501).
RESULTS
ATM status affects p16Ink4a in Rb-deficient tumors. Rb/mice
develop several types of “Rb-deficient” tumors as a consequence of
normal allele inactivation in somatic cells (3). We analyzed pri-
mary thyroid C cell tumors developed in Rb/; ATM/ (aver-
age age at examination [AE]  standard error of the mean
[SEM]  12.5  1.5 months), Rb/; ATM/ (AE  7.1  1.3
months), and Rb/; ATM/ (AE 5.4 1.3 months) mice. C
cell tumors were not detected in Rb/;ATM/ (AE 9.4 1.4
months) mice (Fig. 1A). Carcinoembryonic antigen (CEA) and
Ki67 were frequently expressed in both Rb-deficientATM/ and
Rb-deficient ATM/ tumors but were infrequently expressed in
Rb-deficient ATM/ tumors (Fig. 1A; see also Table S1 in the
supplemental material). Rb/; ATM/ mice exhibited signifi-
cantly poorer survival than didRb/;ATM/mice (Fig. 1C). As
we previously reported (15), primary Rb-deficient ATM/ tu-
mors exhibited frequent expression of DDR markers, including
ATM phosphorylated at serine 1981 (ATMpS1981), histone variant
H2AXphosphorylated at serine 139 (H2AX), andp53phosphor-
ylated at serine 15 (p53pS15) (see Fig. S1 in the supplemental ma-
terial). Ataxia telangiectasia Rad-3-related protein kinase (ATR)
was frequently expressed in Rb-deficient, ATM-deficient tumors,
and Rb-deficient ATM/ tumors showed significant accumula-
tion of H2AX. ATM heterozygosity reduced the frequency of
ATMpS1981 to 	10% (see Fig. S1 in the supplemental material);
this may explain the haploid insufficiency of the ATM locus in
Rb-deficient C cell tumors. Consistent with our previous report,
Rb-deficient tumors frequently expressed senescencemarkers, in-
cluding histone H3 trimethylated at lysine 9 (H3K9me3), hetero-
chromatin protein 1 (HP1), and p16Ink4a (Fig. 1B). In contrast
to the previously studied Rb-deficient N-ras/ tumors (15), Rb-
deficient ATM/ or Rb-deficient ATM/ tumors retained fre-
quent expression of H3K9me3, HP1, and p19Arf. However,
p16Ink4a expression was very infrequent in these tumors, in sharp
contrast to the frequent DNMT1 expression (Fig. 1B). Because
promoter methylation is a common mechanism for Ink4a gene
inactivation, we suspected that ATM activity might influence the
Ink4a expression level via regulation of DNMT1.
Human sporadic medullary thyroid carcinomas (MTCs) can
be classified into two groups: one with high-level pRB expression
and the other with low-level pRB expression (15). A total of 200
cells were randomly selected and evaluated for immunopositive
nuclear staining in all tumors, and tumors were classified accord-
ing to the frequency of immunopositive cells into two groups,
with cutoff values of 50% for high-level expression and 	50%
for low-level expression. In the current study, we analyzed 5 cases
with high-level and 5 caseswith low-level pRB expression. Five out
of five cases with low pRB levels showed low expression levels of
ATMpS1981. Four out of the five cases with low pRB levels showed
high DNMT1 expression levels; all four of these cases showed low
p16INK4a expression levels (see Fig. S2A to D in the supplemental
material). One case with low pRB and exceptionally low DNMT1
levels showed very high p16INK4a expression levels. Because pRB
inactivation is frequently detected in esophageal cancers, we also
tested this correlation in human esophageal squamous cell carci-
nomas (SCCs). We then detected 8 out of 10 cases with low pRB
expression levels. Six out of the eight cases with low pRB levels
showed high ATMpS1981, low DNMT1, and high p16INK4a expres-
sion levels (see Fig. S2E to G in the supplemental material). Al-
though the ATM activation status varied in these two types of
human cancers, the strict correlation of ATMpS1981, DNMT1, and
p16INK4a in low-level pRB-expressingMTCs and esophageal SCCs
supports our hypothesis that ATM status might determine
p16INK4a expression via regulation of DNMT1 in the absence
of pRB.
ATMstatus affectsp16Ink4a inRb-deficientmouse embryonic
fibroblasts. Biallelic loss of ATM shortened the life span of Rb/
embryos (average life span, 
E13.5) by approximately 3 days.
Therefore, we prepared MEFs of varied Rb and ATM genotypes
fromE10.0 embryos. Compared to cells derived fromRb-deficient
ATM/ C cell tumors, Rb/; ATM/MEFs adapted easily to
adhesive culture conditions. Thus, we extensively analyzedMEFs.
Upon a 3T3 protocol assay, Rb/;ATM/ and Rb/;ATM/
MEFs achieved infinite proliferation significantly earlier than did
Rb/ or ATM/MEFs (Fig. 2A). In addition, Rb/; ATM/
and Rb/; ATM/ MEFs but not Rb/ or ATM/ MEFs
could formcolonieswhenplated at a low cell density (Fig. 2B, left).
These signs of immortalization were more evident in Rb/;
ATM/ than in Rb/; ATM/MEFs (Fig. 2A and B). Consis-
tently, immunoblotting showed a tight correlation between
DNMT1 and p16Ink4a levels in Rb-negative MEFs depending on
the ATM status (Fig. 2B).
Both the abundance and activity of ATM (ATMpS1981) were
markedly increased, and the DNMT1 level was downregulated in
Rb/ MEFs compared to Rb/ cells (Fig. 2C). A previous re-
port, however, indicated that RB loss upregulates DNMT1 tran-
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FIG 1 Analysis of Rb-deficient C cell tumors with various ATM genotypes. (A) Thyroid tumors developed in mice of the indicated genotypes at the indicated
months of age were photographed, and the tissues were then analyzed by hematoxylin-eosin (HE) staining and immunostaining with antibodies to the indicated
proteins. The frequency of immunopositive cells per 200 normal thyroid or tumor cells was quantified. Columns show means and SEM. Scale bars, 1 mm in
macroscopic and 100 m in microscopic pictures. (B) Serial sections of the same tumors were immunostained with antibodies to the indicated proteins and
analyzed as described above for panel A. (C) Survival rate in mice of the indicated genotypes. Data are expressed as percent survival.
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scription by severalfold (32). These findings suggested that the
genetic interaction between Rb and ATMmight regulate DNMT1
at the posttranscriptional level.
Rb deletion upregulated p16Ink4a, p21Waf1/Cip1, and Suv39h1
with concomitant increases in the levels of H3K9me3 and HP1.
Simultaneous deletion of ATM remarkably decreased the level of
p16Ink4a and reciprocally upregulated DNMT1 and proliferating
cell nuclear antigen (PCNA) (Fig. 2C). Heterozygous deletion of
ATM also upregulated DNMT1 to a level slightly lower than that
with the homozygous deletion (Fig. 2B, right). Furthermore, Rb
deletion induced Chk2pT68 and p53pS15, which was significantly
attenuated by the simultaneous deletion of ATM. In contrast,
Rb/; ATM/ MEFs showed marked increases in the levels of
H2AX, ATR, and Chk1pS345 (Fig. 2C). Introduction of pRB into
Rb/ MEFs decreased ATMpS1981 and increased DNMT1 levels
(Fig. 2D). Depletion of DNMT1 significantly increased p16Ink4a
levels in Rb/; ATM/ MEFs and eliminated their ability to
form colonies when plated at a low density (Fig. 2E). We previ-
ously demonstrated that an additional Ink4a deletion immortal-
ized Rb/MEFs at early passage (15). All these observations sug-
gest that suppression of the Ink4a gene by DNMT1 might be the
major mechanism underlying the immortal growth of Rb/;
ATM/MEFs.
To assess the role of induced and activated ATM in Rb/
MEFs, we depleted ATM from Rb/ and Rb/ MEFs. ATM
depletion inRb/MEFs reducedChk2pT68 and p53pS15 levels and
induced H2AX, consistent with the findings forRb/;ATM/
MEFs. However, Chk1pS345 was also attenuated by ATM deple-
tion, contrary to our observations of Rb/; ATM/MEFs. Im-
portantly, ATMdepletion inRb/MEFs upregulatedDNMT1 to
a level similar to that seen in Rb/; ATM/ MEFs, with recip-
rocal downregulation of p16Ink4a. Interestingly, ATM depletion
FIG 2 Analysis of Rb/ MEFs of various ATM genotypes. (A) 3T3 protocol assay of MEFs with the indicated genotypes. MEFs were freshly prepared from
embryos of timed pregnant inbred mice and cultivated for 3 passages before the start of the 3T3 assay. The cumulative multiplicity in the representative cultures
at the indicated passage number is illustrated in the graph. WT, wild type. (B) Representative results from colony formation assays with MEFs of the indicated
genotypes plated at 1 103 cells per 60-mm dish and cultured for 14 days. (C) Immunoblotting analysis of MEFs of the indicated genotypes with antibodies to
the indicated proteins. (D) Rb/MEFs infected with retroviruses expressing the indicated proteins were selected and analyzed by immunoblotting. (E) Rb/;
ATM/MEFs infectedwith lentiviruses expressing shRNAs that target the indicated genes were analyzed by a colony formation assay and immunoblottingwith
antibodies to the indicated proteins. #1 and #2 indicate independently designed shRNAs targeting DNMT1. (F) Rb/ or Rb/MEFs infected with lentiviruses
expressing the shRNAs that target the indicated geneswere selected and analyzed by immunoblotting. GFP, green fluorescent protein. (G)Rb/;ATM/MEFs
transduced with vectors expressing the indicated proteins were selected and analyzed by immunoblotting.
Epigenetic Functions of the RB-ATM Interaction
August 2013 Volume 33 Number 16 mcb.asm.org 3117
 o
n









from Rb/ cells rather slightly increased both DNMT1 and
p16Ink4a levels (Fig. 2F). These findings strongly indicate that the
Rb status is a critical determinant of the regulatory interaction of
ATM, DNMT1, and p16Ink4a. Immunofluorescence (IF) analysis
and Comet assays of ATM-depleted cells showed results consis-
tent with those obtained by immunoblotting (see Fig. S3A in the
supplemental material). In addition, ATM depletion allowed
Rb/ but not Rb/ MEFs to form colonies under low-density
plating conditions (see Fig. S3D in the supplemental material).
Interestingly, the simultaneous depletion of both ATM and
p16Ink4a was sufficient to immortalizeRb/MEFs (see Fig. S3E in
the supplemental material). These findings suggest that inactiva-
tion of the CDKIs-pRB pathway in combination with a deficient
DDR is sufficient to immortalize MEFs.
Introduction of ATM into Rb/; ATM/ MEFs recovered
theDDR, downregulatedDNMT1 but not DNMT3b, and rescued
p16Ink4a (Fig. 2G). ATM reconstitution significantly suppressed
colony formation by Rb/; ATM/ MEFs when cultured at a
low density (see Fig. S4A in the supplemental material). On the
other hand, the effect of gene transduction on cell proliferation
became visible only after day 14 (see Fig. S4B and C in the supple-
mental material). All our assessments of cellular proteins were
done at days 10 to 12 after gene transduction. This suggests that
most of the above-mentioned changes preceded the effects on the
cell cycle possibly given by ATM. ATM introduced into
Rb/; ATM/MEFs exhibited a high level of phosphorylation
and inducedDDR activation, which was significantly antagonized
by pRB (see Fig. S4D in the supplemental material). A mutant
form of ATM in which serine 1981 was changed to alanine
(ATMS1981A) significantly failed to achieve these functions (see
Fig. S4 in the supplemental material). Introduction of ATM or
ATMS1981A into an Rb-deficient ATM/ C cell adenocarcinoma
cell line showed results highly similar to those obtained with
Rb/; ATM/MEFs (see Fig. S5 in the supplemental material).
Taken together, these findings suggest that Rb and ATM cooper-
atively regulate MEF immortalization by modulating the p16Ink4a
level via control of DNMT1 abundance.
ATMregulates theDNAmethylation status of the Ink4a pro-
moter. To assess the significance of the reciprocal correlation of
DNMT1 andp16Ink4a, we examined themethylation status ofCpG
islands residing in the Ink4a promoter by bisulfite sequencing.We
observed that Rb loss significantly decreased DNAmethylation in
the Ink4a promoter region (Fig. 3A and C). Surprisingly, simulta-
neous ATM deletion induced hypermethylation in the same re-
gion of the Ink4a promoter (Fig. 3B and C). Introduction of ATM
but not ATMS1981A into Rb/; ATM/ MEFs carrying Ink4a
promoter hypermethylation and following cultivation under nor-
mal conditions for 10 days remarkably reduced the number of
methylated CpG nucleotides in the Ink4a promoter (Fig. 3B and
C; see also Fig. S6A in the supplemental material). Bisulfite PCR
with either unmethylation- or methylation-specific primers
showed similar results (see Fig. S7A in the supplementalmaterial).
Both treatment with the ATM-specific kinase inhibitor KU-55933
and, more importantly, the introduction of pRB antagonized the
ATM function to induce the hypomethylation status of the Ink4a
promoter (Fig. 3B and C; see also Fig. S6A in the supplemental
material). Reintroduction of only pRB into Rb/; ATM/
MEFs caused an insignificant change in the Ink4a promotermeth-
ylation status (Fig. 3B and C; see also Fig. S6A in the supplemental
material). Treatment of Rb/; ATM/MEFs expressing exoge-
nous ATM and pRB with KU-55933 caused an insignificant in-
crease in the Ink4a promotermethylation level comparedwith the
marked increase in the Ink4a promoter methylation level induced
byATMkinase inhibition inRb-deficientMEFs (Fig. 3B andC; see
also Fig. S6A in the supplemental material). We thought that this
variability of ATM function reflected different levels of ATM ac-
tivity because exogenously introduced pRB inhibited ATM acti-
vation (ATMpS1981 and p53pS15), increased DNMT1 abundance,
and suppressed p16Ink4a to levels comparable to those observed in
Rb-deficient MEFs treated with KU-55933. Therefore, further
treatment of Rb/; ATM/ MEFs expressing exogenous ATM
and pRB with KU-55933 did not cause significant changes in ei-
ther ATM activation, DNMT1 abundance, or the p16Ink4a protein
level (Fig. 3D). Interestingly, DNMT1 suppression by specific
shRNAs or methyltransferase inhibitors significantly reduced
DNA methylation, particularly in the CpG nucleotides closer to
the transcription start site of the Ink4a gene (Fig. 3C; see also Fig.
S6A in the supplemental material).
ATM inhibition in the Rb-negative context suppressed the
Ink4a mRNA level (see Fig. S7B in the supplemental material).
Chromatin immunoprecipitation (ChIP) indicated that simulta-
neous deletion of Rb and ATM significantly enhanced binding of
DNMT1 and the bivalent histone mark to the Ink4a promoter.
However, ATM reconstitution in Rb/; ATM/ MEFs dimin-
ished DNMT1 binding, with insignificant changes in the histone
mark, particularly in the proximal promoter region (Fig. 3E). The
effect ofRb andATM statuses onDNMT1binding to the proximal
region of the Ink4a promoter was confirmed by quantitative ChIP
analysis (Fig. 3F). However, the transcription level ofDNMT1was
insignificantly affected by the ATM status in an Rb-negative con-
text (see Fig. S7C in the supplemental material). Taken together,
these observations imply that activated ATM influences the Ink4a
promoter methylation status by regulating DNMT1 primarily at
the posttranscriptional level, and pRb antagonizes these ATM
functions by attenuating its activation.
Active ATM dictates ubiquitination of DNMT1 in the ab-
sence of Rb. To further explore the functional relationship be-
tween ATM andDNMT1, we introduced ATMor ATMS1981A into
Rb/; ATM/ MEFs and observed the fate of endogenous
DNMT1 by IF. Compared to the vector control, ATM but not
ATMS1981A significantly reduced the intensity of the DNMT1 sig-
nal in the nucleus. In addition, we detected a certain degree of
colocalization of exogenous ATMpS1891 and endogenous DNMT1
in the nucleus. However, the ATMS1981A andDNMT1 signals were
mutually exclusive in the majority of examined cells (Fig. 4A).
DNMT1 is regulated by ubiquitination-dependent degrada-
tion at the proteasome (33, 34). Treatment of the ATM-reconsti-
tuted Rb/; ATM/ MEFs with a proteasome inhibitor,
MG132, increased the DNMT1 level in the nucleus and enhanced
its colocalization with ATMpS1891 in a time-dependent manner
(Fig. 4B). In addition, MG132 treatment of vector-transduced
Rb/; ATM/ MEFs did not affect the DNMT1 protein level;
however, it did dramatically increase the DNMT1 level in ATM-
reconstituted cells. Furthermore, MG132 treatment induced ac-
cumulation of acetylated and polyubiquitinated DNMT1 in
ATM-reconstituted Rb/;ATM/MEFs (Fig. 4C, lane 5), indi-
cating that ATM accelerates DNMT1 ubiquitination in the ab-
sence of Rb. Treatment of Rb/; ATM/MEFs simultaneously
with MS275 (HDAC1 inhibitor) and MG132 decreased DNMT1
abundance and enhanced accumulation of the acetylated and
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polyubiquitinated forms of DNMT1 (Fig. 4C, lane 3), suggesting
that increased acetylation of DNMT1 is sufficient to trigger its
ubiquitination. Taken together, these findings suggest that ATM
promotes acetylation-driven ubiquitination following degrada-
tion of DNMT1 in Rb-deficient cells.
Next, we asked whether activated ATM regulates the functions
of enzymes involved in regulation of DNMT1 acetylation. The
immunoprecipitation assay of lysates from MG132-treated cells
with DNMT1-specific antibody indicated that DNMT1 is bound
to HDAC1 in vector-transduced Rb/; ATM/ MEFs. Intro-
FIG 3 DNA methylation status of the Ink4a promoter region in MEFs of various Rb and ATM genotypes. (A) Results of bisulfite sequencing of the Ink4a
promoter region in Rb/ or Rb/MEFs. (B) Rb/; ATM/MEFs were transfected with the vectors expressing the indicated proteins, selected, cultured for
an additional 10 days, and thereafter treated with the indicated reagent (KU-55933 at 10 M for 7 days) and analyzed. (C) Statistical analysis of the results of
bisulfite sequencing of the Ink4a promoter region in MEFs of the indicated genotypes that were transfected with the expression vectors or infected with
lentiviruses expressing shRNAs that target the indicated genes, selected for 72 h, and treated with the indicated reagents (trichostatin A [TSA] at 2M for 3 days,
KU-55933 at 10 M for 5 days, and 5-AzadC at 2 M for 3 days). *, P 	 0.01 by Mann-Whitney test. (D) Immunoblotting analysis of MEFs of the indicated
genotypes with antibodies to the indicated proteins.MEFswere transfectedwith the vectors expressing the indicated proteins, selected, cultured for an additional
10 days, and thereafter treated with the indicated reagent (KU-55933 at 10 M for 5 days) and analyzed. (E) ChIP assay of the Ink4a promoter region in MEFs
of the indicated genotypes. Rb/; ATM/ MEFs were transduced with vectors expressing the indicated proteins, selected, and analyzed for binding of the
indicated proteins by PCR with specific primers (see Fig. S6B and Table S5 in the supplemental material). Proximal, middle, and distal regions are relative to the
transcription start site (see Fig. S6B in the supplemental material). (F) Quantitative ChIP assay of the Ink4a promoter region (positions
44 to149) inMEFs
of the indicated genotypes. Rb/; ATM/MEFs were transduced with vectors expressing the indicated proteins, selected, and analyzed for DNMT1 binding
by qPCR with specific primers (see Fig. S6B and Table S5 in the supplemental material).
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duction of ATM precluded HDAC1 from the DNMT1 complex
and instead recruited Tip60 acetyltransferase and UHRF1 E3 li-
gase (Fig. 4D). However, the introduced ATMS1981A largely failed
to exhibit this function (Fig. 4D). The immunoprecipitation assay
with an ATM-specific antibody provided results consistent with
those obtained in the experiments described above (Fig. 4D). In
addition, the immunoprecipitation assay of lysates from Rb/
MEFs with ATM or DNMT1 antibodies indicated that endoge-
nous ATM is bound to DNMT1, and treatment with MG132 or a
formaldehyde cross-linker enhanced their binding. Although the
ATM level is lower than that in Rb/ MEFs, we so far did not
detect endogenous ATM-DNMT1 binding in Rb/ MEFs even
when treated with MG132 or by formaldehyde cross-linking (Fig.
4E). In addition, the introduction of ATM into Rb/; ATM/
MEFs upregulated Tip60 and suppressed the HDAC1 protein lev-
el; however, pRB antagonized this effect of ATM (Fig. 4F), sug-
gesting that activated ATM controls DNMT1 acetylation even by
regulating the abundances of HDAC1 and Tip60. Tip60 was re-
cently shown to destabilize DNMT1 via an acetylation-driven
ubiquitination mechanism (35); however, the current study pro-
poses that activatedATMplays a critical role in the assembly of the
DNMT1 degradation complex. Tip60 depletion from ATM-re-
constituted Rb/; ATM/ MEFs induced a significant down-
regulation of ATMpS1981 and rescued DNMT1 via suppression of
its acetylation (Fig. 4G). In contrast, without ATM, overexpressed
Tip60 did not affect either the abundance or acetylation of
DNMT1 (Fig. 4H), implying that ATM essentially mediates
Tip60-induced DNMT1 acetylation. Furthermore, introduction
of pRB into ATM-reconstituted Rb/; ATM/MEFs disrupted
the ATM-DNMT1-Tip60-UHRF1 (DNMT1 degradation) com-
plex (Fig. 4I). Taken together with our findings that pRb regulates
ATM activation (Fig. 2D) and that ATM-mediated Tip60 func-
tions to acetylate DNMT1 (Fig. 4F to H), these observations indi-
cated a key role for pRB in regulating the DNMT1 degradation
complex.
We next assessed the direct effects of cell lysates from MEFs
with various Rb and ATM statuses on the activity of DNMT1 in
vitro. Cell lysates from Rb/; ATM/ MEFs increased the
DNMT1 activity in a dose-dependentmanner, whereas cell lysates
from Rb/; ATM/MEFs significantly attenuated DNMT1 ac-
tivity. Lysates from wild-type MEFs showed no significant effects
on DNMT1 activity (Fig. 5A), whereas lysates from ATM-recon-
stituted Rb/; ATM/ MEFs significantly decreased DNMT1
activity. Finally, lysates from Rb/; ATM/ MEFs transduced
with ATMS1981A slightly attenuated DNMT1 activity (Fig. 5B).
These findings support the notion that pRb stabilizes DNMT1 by
antagonizing ATM activation.
FIG 4 Effects of pRB and ATM on the DNMT1 degradation complex. (A) IF
analysis of the indicated proteins in Rb/; ATM/ MEFs transduced with
vectors expressing the indicated proteins. (B) IF analysis of Rb/; ATM/
MEFs transduced with vectors expressing the indicated proteins and treated
with vehicle (DMSO) or 5 M MG132 for the indicated periods of time.
Numbers in parentheses indicate percentages of the representative phenotype
that appeared in all analyzed cells. (C) Lysates from Rb/; ATM/ MEFs
transduced with vectors expressing the indicated proteins and treated with the
indicated reagents were immunoprecipitated with DNMT1-specific antibody
and analyzed by immunoblotting. Concentrations and durations of treat-
ments are as follows: MS275 at 5 M for 48 h, cycloheximide (CHX) at 2.5
g/ml for 12 h, and MG132 at 5 M for 12 h. Ub, ubiquitin (D) Lysates from
Rb/; ATM/MEFs transduced with vectors expressing the indicated pro-
teins were treated with 5 M MG132 for 12 h, immunoprecipitated with an-
tibodies to DNMT1 or ATM, and analyzed by immunoblotting. (E) Lysates
fromMEFs of the indicated genotypes arrested in S phase and treated with the
indicated reagents were immunoprecipitated (IP) with antibodies to DNMT1
or ATM and analyzed by immunoblotting (IB). Cells were arrested in S phase
by a double-thymidine block at 2 mM for 18 h (first block), released for 9 h,
and blocked for another 17 h (second block); MG132 was used at 5 M for 12
h; and cross-linking was performed with a 1% formaldehyde solution for
10 min at room temperature and terminated with 0.125M glycine. (F) Rb/;
ATM/ MEFs were transduced with vectors expressing the indicated pro-
teins, selected with 4 g/ml puromycin and 8 g/ml blasticidin S for 5 days,
and analyzed by immunoblotting using antibodies specific to the indicated
proteins. (G)Rb/;ATM/MEFs transduced with vectors expressing ATM
were infected with lentiviruses expressing shRNAs that target the indicated
genes, selected, and analyzed by immunoblotting. (H) Rb/; ATM/MEFs
transduced with vectors expressing the indicated proteins were analyzed by
immunoblotting. Ac-K, acetylated lysine. (I) Lysates from Rb/; ATM/
MEFs transduced with vectors expressing the indicated proteins were treated
with 5MMG132 for 12 h, immunoprecipitatedwithATM-specific antibody,
and analyzed by immunoblotting.
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Subcellular fractionation and IF analysis of MG132-treated
Rb/; ATM/MEFs indicated that endogenous DNMT1 is lo-
calized predominantly in the chromatin fraction in vector-trans-
duced Rb/; ATM/MEFs, while introduction of ATM signif-
icantly reduced the abundance of DNMT1 in the chromatin
fraction and increased it in the cytosolic fraction, and this was
antagonized by the simultaneous introduction of pRB (Fig. 5C
and D). In the same setting, pRB reduced the level of exogenous
ATM in the chromatin fraction. These findings suggest that the
level of insoluble DNMT1 (chromatin fraction) is affected by the
status of ATMandpRB, and the localization of ATM to chromatin
is dynamically controlled by pRB.
TheATMkinase domain interactswith theDNMT1 catalytic
domain. To further characterize the physical interaction between
ATM and DNMT1, we generated various HA-tagged ATM frag-
ments (see Fig. S8A in the supplemental material) and HA- or
FLAG-tagged DNMT1 fragments (see Fig. S8B) and examined
their interactions when introduced into Rb/; ATM/ MEFs.
We found that ATM fragments containing the kinase domain
were able to bind to and trigger acetylation and degradation of
endogenous DNMT1 when introduced into Rb/; ATM/
MEFs (Fig. 5E). Consistent with this, these ATM fragments were
able to activate downstream targets, including Chk2 and p53,
when overexpressed (Fig. 5F). Furthermore, DNMT1 fragments
containing the catalytic domain were able to bind to exogenous
ATM when both were introduced into Rb/; ATM/ MEFs
(Fig. 5G). In summary, these findings indicate that the region in
the ATM kinase domain (positions 2740 to 3056) and the region
in the DNMT1 catalytic domain (positions 1504 to 1632) are nec-
essary for ATM-DNMT1 binding.
The pRB-ATM-DNMT1 pathway regulates DNA methyl-
ation status.Wenext surveyed for genes possibly regulated by the
pRB-ATM-DNMT1 pathway. We performed microarray analysis
of Rb/; ATM/MEFs to identify genes that simultaneously fit
two criteria, i.e., (i) being repressed by endogenous DNMT1 and
(ii) being upregulated by exogenous ATM, conceivably through
DNMT1 inactivation. We identified 318 genes commonly up-
regulated in 2 combinations of experiments (cutoff point 
2.0), namely, Rb/; ATM/MEFs depleted for DNMT1 ver-
sus the control and those reconstituted with ATM versus the con-
trol (Fig. 6A; see also Table S6 in the supplemental material). Of
these genes, we focused on 3 cancer-related genes, Shc2, FoxO6,
and Noggin. The frequency of methylated CpG nucleotides in the
promoter regions of these genes was invariably high in Rb/;
ATM/ MEFs (Fig. 6B to G). Importantly, reintroduction of
ATM intoRb/;ATM/MEFsmarkedly reduced the frequency
ofmethylatedCpGs in the promoter regions of these genes after 10
days of cultivation under normal conditions. Furthermore, addi-
tional introduction of pRB antagonized the ATM-induced sup-
pression of CpG island methylation of the promoter regions of
these genes (Fig. 6B to G; see also Fig. S9 in the supplemental
material). Taken together, these findings suggest that in the Rb-
negative context, the ATM-DNMT1 interaction regulates the
DNA methylation status of gene promoters.
DISCUSSION
The current study revealed at least a part of the mechanism that
links the DDR to cellular senescence in the Rb-deficient context
and also a previously unexpected role of the genetic interaction
between RB and ATM in controlling DNMT1 protein stability
(Fig. 7). pRB has been linked to the ATMactivation status via DSB
formation (13). Our current study proposed additional mecha-
nisms including control of Tip60-dependent ATM autophos-
phorylation and recruitment of ATM to chromatin. We further
FIG 5 Physical interaction between ATM and DNMT1. (A) Measurement of
the dose-dependent effects of the lysates fromMEFs of the indicated genotypes
on DNMT1 enzyme activity. (B) Measurement of the dose-dependent effects
of the lysates from Rb/; ATM/MEFs transduced with vectors expressing
the indicated proteins on DNMT1 enzyme activity. (C) Cytosolic (C), nuclear
(N), or chromatin (Ch) protein fractions from Rb/; ATM/MEFs trans-
duced with vectors expressing the indicated proteins and treated with 5 M
MG132 for12hwereanalyzedby immunoblotting. (D) IFanalysiswithantibodies
specific to the indicated proteins in Rb/; ATM/MEFs transduced with vec-
tors expressing the indicated proteins. Scale bars, 20m. (E) Lysates fromRb/;
ATM/MEFs transducedwith vectors expressing the indicatedproteins (seeFig.
S8A in the supplemental material) were untreated or treated with 5 MMG132
for 12 h (indicated in parentheses), immunoprecipitated, and analyzed by immu-
noblotting. (F) Lysates from cells prepared as described above for panel E were
analyzedby immunoblottingwithantibodies to the indicatedproteins. (G)Lysates
from FLAG-ATM-reconstituted Rb/; ATM/MEFs transduced with vectors
expressing the indicated proteins (see Fig. S8B in the supplementalmaterial) were
treated with 5MMG132 for 12 h, immunoprecipitated with antibodies specific
to the indicated proteins, and analyzed by immunoblotting.
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demonstrated that activated ATM physically binds to DNMT1 in
a complex with Tip60 and UHRF1 and promotes the acetylation-
driven ubiquitination of DNMT1. Recently, Du et al. reported a
similar regulation of DNMT1 ubiquitination by Tip60 (35). We
demonstrated here that Tip60 requires the presence of ATM to
initiate DNMT1 acetylation and following ubiquitination. In ad-
dition, Tip60 is also known to acetylate ATMK3016 that further
induces ATM autophosphorylation at multiple sites, including
ATMS1981, which is required for DDR activation (35, 36) and
DNMT1 degradation (observed in this study). Therefore, there is
a possibility that Tip60 regulates both ATM and DNMT1 in the
same complex (Fig. 7). Our data also indicate that the unavailabil-
ity of pRB disables HDAC-mediated protection and promotes the
Tip60-mediated inhibition of DNMT1 via ATM modifications
(Fig. 7).
The current study indicated that the high level of DNMT1 in
cells lacking both Rb and ATM is a rate-limiting step in maintain-
ing the high level of DNA methylation in several cancer-related
gene promoters, including Ink4a. A previous report, using a so-
matic knockout of DNMT1 in HCT116 cell clones, showed an
FIG 6 Genome-wide survey for genes epigenetically regulated by the pRB-ATM-DNMT1 nexus. (A) Venn diagram of microarray analysis. Rb/; ATM/
MEFs were transduced with vectors expressing the indicated proteins or infected with lentiviruses expressing the shRNAs that target the indicated genes, selected
with 4g/ml puromycin or 8g/ml blasticidin S for 72 h, cultured for an additional 4 days under normal culture conditions, and analyzed bymicroarray analysis.
Commonly upregulated genes in the 2 combinations of experiments are shown in red. A list of genes and their ontology are indicated in Table S6 in the
supplemental material. (B and C) Results of bisulfite sequencing of the Shc2 promoter region in MEFs of the indicated genotypes transduced with vectors
expressing the indicated proteins and their statistical analysis. (D and E) Results of bisulfite sequencing of the FoxO6 promoter region in MEFs of the indicated
genotypes transducedwith vectors expressing the indicated proteins and their statistical analysis. (F andG)Results of bisulfite sequencing of theNoggin promoter
region inRb/;ATM/MEFs transducedwith vectors expressing the indicated proteins and their statistical analysis. A detailed statistical analysis of the effects
of pRB and ATM on the frequency and location of methylated CpG (Me-CpG) nucleotides in the promoters of these three representative genes is shown in Fig.
S9 in the supplemental material.
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insignificant difference in the INK4a promotermethylation status
betweenDNMT1/ andDNMT1/ cells (37). Previouswork by
the same group indicated that DNMT3B, which was unaffected by
pRb or ATM in ourRb/;ATM/ cells (Fig. 2G), is functionally
redundant with DNMT1 inmaintaining themethylation status of
the INK4a promoter (38). Fournel et al. also demonstrated with
another cell line that DNMT1 downregulation was sufficient to
reduce the DNA methylation of the INK4a promoter (39). In ad-
dition, Robert et al. demonstrated that DNMT1 inhibition is a
majormechanismbywhich 5-aza-2’-deoxycytidine (5-AzadC) re-
activates the INK4a promoter (40). Taken together, these findings
indicate that the role of DNMT1 can be rate limiting in the regu-
lation of at least the Ink4a promoter methylation status and that
this might depend on the cellular context and functional redun-
dancy with other DNA methyltransferases.
DDR activation has been demonstrated to contribute to onco-
gene-induced senescence (OIS) (41); however, the mechanism
linking the DDR to cellular senescence was not known. Most on-
cogenic signals merge upon the transcriptional upregulation of
D-type cyclins, which, in cooperation with CDK4/6, inactivate
pRB by initiating its phosphorylation. Thus, we suspect that pRB
inactivation and the consequent ATM activation might be a com-
mon mechanism of various types of OIS.
Furthermore, our data indicated a possibility that both pRB
and ATM are simultaneously inactivated with reciprocal upregu-
lation of DNMT1 in half of sporadic human MTC cases. A previ-
ous study demonstrated simultaneous mutations of RB and ATM
in lung adenocarcinomas (42). These observations suggest that
the pRB-ATM-DNMT1 nexus might be frequently deregulated in
human cancers. Evenwithoutmutations inRB andATM, a variety
of oncogenic signals can affect the activation statuses of both pRB
and ATM. Furthermore, tumor cells typically exhibit a certain
level of DSBs, as depicted, for instance, by positive H2AX stain-
ing observed in their nucleus; this might lead to varied levels of
ATM activation. Therefore, there is a possibility that a significant
portion of cellular information is translated onto epigenetic mod-
ifications via the pRB-ATM-DNMT1 nexus. If so, this scenario
may provide at least a part of the mechanism of the abnormal
DNA methylation pattern prevalently found in human cancers.
This expectation may then endow us with an interesting insight
into the future rationale for epigenetic therapy of cancers. Finally,
it is noteworthy that Rb deficiency in mouse embryos showed
abnormal stem cell activity in many lineages (3, 10). There is a
possibility that pRB controls the epigenetic status during develop-
mental processes through the pRB-ATM-DNMT1 nexus.
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